Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
29.75
+0.93 (3.21%)
Aug 15, 2025, 10:49 AM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| U.S. Bracing & Support | 469.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Bracing & Support Growth | 5.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Other P&R | 270.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Other P&R Growth | -0.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International P&R | 357.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International P&R Growth | 3.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Reconstructive | 505.62M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| U.S. Reconstructive Growth | 13.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Reconstructive | 504.05M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Reconstructive Growth | 48.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prevention & Recovery Capital Expenditures | 34.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prevention & Recovery Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconstructive Capital Expenditures | 146.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconstructive Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Prevention & Recovery Adjusted EBITDA | 159.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prevention & Recovery Adjusted EBITDA Growth | 7.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconstructive Adjusted EBITDA | 216.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconstructive Adjusted EBITDA Growth | 40.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| United States | 1.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 7.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign Locations | 861.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Foreign Locations Growth | 26.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|